Horacio R. Marquez
Buy, Sell or Hold: Ford Motor Co.'s (NYSE: F) Turnaround Could Put Investors on the Fast Track to Profit
Back on July 28, 2008, I recommended buying a speculative stake in Ford Motor Co. (NYSE: F). The stock has more than doubled in value since then, and I believe it's positioned for even more gains.
Let me tell you why.
Investing in a company as it turns around from a highly distressed situation is one of the most profitable investments one can make.
That's why I am always looking for these rare situations, which can play a very important role in a portfolio, even with a small initial investment. And right now there are a few very strong signals that the U.S. auto sector, which was demolished by the financial crisis, is going to bounce back stronger than ever.
Buy, Sell or Hold: Keep Your Portfolio Healthy With Campbell Soup Co. (NYSE: CPB)
That's because most analysts think of Campbell the same way they think of many other consumer staples businesses – as a stable, slow moving business with no real short-term catalyst for growth.
You see, very few remember the tremendous upside that Warren Buffet realized when he invested in another "dull" staples business, The Coca-Cola Co. (NYSE: KO), just prior to a major overseas expansion.And it's precisely that kind of campaign Campbell has mounted – expanding its businesses in Russia, China, and other emerging economies to great success.
Buy Sell or Hold: The SPDR Gold Trust ETF Will Rally in 2010, as Recent Dollar Strengthening Loses Steam
Gold prices surged to a record high $1226.10 an ounce on Dec. 3, but have since retreated. Meanwhile, the U.S. dollar has been weak for many months, but shown signs of strength in the past week.
So what's next for the dollar and the price of commodities like gold?
In order to answer that question we must look at the factors that brought us here: loose monetary policy and government stimulus.
Buy, Sell or Hold: Government's HeavyHanded Plans Spawn Profits With These Three Top Stocks for 2010
When government boosts its involvement in the economy, there's a predictable impact on interest rates, taxes, inflation, the country's currency and even its stock market. As a veteran global investor, I've seen this play out time and again in emerging-market economies, where it's commonplace for government to play an active and heavy-handed role.
I know from my years of experience just what to expect each and every time this story plays out. And that's not all.
I also know how to turn this special knowledge into beat-the-market profits.
Here in the United States, the Obama administration and the U.S. Federal Reserve are like two elephants that have been put to work brutishly reshaping the U.S. economy. We're already experiencing the effects of big government involving itself in the private sector. Expect the dollar to fall even more – after year-end profit-taking ends. Also expect a further deployment of government-stimulus money to industries where the United States has a large competitive advantage and can generate domestic jobs.
We'll be only too happy to ride the resulting economic shifts for profit.
In fact, as part of this installment of "Buy, Sell or Hold" – I've identified three of the best profit opportunities for the New Year. The three "must-own" companies – each poised to benefit from these shifts – are: Corning Inc. (NYSE: GLW), The Boeing Co. (NYSE: BA) and Cypress Semiconductor Corp. (NYSE: CY). We offer them to you here as part of a Money Morning "Outlook 2010" Special Report.
Buy, Sell or Hold: Johnson & Johnson (NYSE: JNJ) Brings a Strong Business Model and 100 Years of Experience Into 2010
I know Johnson & Johnson (NYSE: JNJ) very well. I live in the heart of big pharma country: Princeton, N.J. And I have been interacting regularly with many people in this industry, including all levels of the Johnson & Johnson management for years.
Johnson & Johnson is a company that my peer analysts and I have admired for decades. And this well-deserved admiration goes well beyond the financial community.
Let me tell you why.
JNJ has a sound business model that emphasizes the development and marketing of top quality drugs and benchmark consumer products. Its strong and stable profit margins – with gross profit north of 70% – and its consistent growth over more than a century are matched by only a handful of companies.
Buy, Sell or Hold: Buffett's Berkshire Hathaway Inc. Has Been Masterfully Managed and Will Continue to Benefit Investors
Last year, on Aug 25, I recommended readers start buying shares of Berkshire Hathaway Inc. (NYSE: BRK.A, BRK.B) in incremental amounts until the end of 2008. I emphasized that Berkshire should be a core, long-term holding in investors’ portfolios and not a stock to trade in and out off. Today, the stock is about 11% [...]
Buy, Sell or Hold: Hold On to the TS&W/Claymore Tax-Advantaged Balanced Fund and Look for More Buying Opportunities
On June 29, I recommended buying the TS&W/Claymore Tax-Advantaged Balanced Fund (NYSE: TYW). The fund is up about 15% since that recommendation and there's been a distribution of about 2% of the initial investment. Not bad for sitting in bonds and equities of global mega-caps that pay high dividends.
Since this is a close-ended balanced mutual fund that pays a very attractive yield, the fund can invest between 50% to 60% in municipal bonds and between 40% to 50% in global equities. It also can trade at a premium or a discount to net asset value.